Wells Fargo’s Marker Therapeutics MRKR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $355 | Hold |
232
| – | – | ﹤0.01% | 5946 |
|
|
2025
Q1 | $285 | Hold |
232
| – | – | ﹤0.01% | 5839 |
|
|
2024
Q4 | $722 | Hold |
232
| – | – | ﹤0.01% | 5784 |
|
|
2024
Q3 | $654 | Hold |
232
| – | – | ﹤0.01% | 5744 |
|
|
2024
Q2 | $1.26K | Sell |
232
-52
| -18% | -$282 | ﹤0.01% | 5690 |
|
|
2024
Q1 | $1.22K | Buy |
284
+1
| +0.4% | +$4 | ﹤0.01% | 5717 |
|
|
2023
Q4 | $1.56K | Buy |
283
+3
| +1% | +$17 | ﹤0.01% | 5695 |
|
|
2023
Q3 | $1.27K | Buy |
280
+3
| +1% | +$14 | ﹤0.01% | 5784 |
|
|
2023
Q2 | $859 | Buy |
277
+4
| +1% | +$12 | ﹤0.01% | 6044 |
|
|
2023
Q1 | $194 | Hold |
273
| – | – | ﹤0.01% | 6459 |
|
|
2022
Q4 | $725 | Buy |
273
+1
| +0.4% | +$3 | ﹤0.01% | 5953 |
|
|
2022
Q3 | $1K | Sell |
272
-1
| -0.4% | -$4 | ﹤0.01% | 6066 |
|
|
2022
Q2 | $1K | Buy |
273
+4
| +1% | +$15 | ﹤0.01% | 6254 |
|
|
2022
Q1 | $1K | Hold |
269
| – | – | ﹤0.01% | 6474 |
|
|
2021
Q4 | $2K | Sell |
269
-100
| -27% | -$743 | ﹤0.01% | 6337 |
|
|
2021
Q3 | $7K | Sell |
369
-3
| -0.8% | -$57 | ﹤0.01% | 5973 |
|
|
2021
Q2 | $10K | Sell |
372
-706
| -65% | -$19K | ﹤0.01% | 5811 |
|
|
2021
Q1 | $23K | Sell |
1,078
-4,113
| -79% | -$87.8K | ﹤0.01% | 5750 |
|
|
2020
Q4 | $75K | Sell |
5,191
-3,477
| -40% | -$50.2K | ﹤0.01% | 5279 |
|
|
2020
Q3 | $130K | Sell |
8,668
-394
| -4% | -$5.91K | ﹤0.01% | 4971 |
|
|
2020
Q2 | $188K | Buy |
9,062
+6,222
| +219% | +$129K | ﹤0.01% | 4774 |
|
|
2020
Q1 | $54K | Sell |
2,840
-314
| -10% | -$5.97K | ﹤0.01% | 5092 |
|
|
2019
Q4 | $91K | Sell |
3,154
-1,705
| -35% | -$49.2K | ﹤0.01% | 5123 |
|
|
2019
Q3 | $248K | Buy |
4,859
+1,716
| +55% | +$87.6K | ﹤0.01% | 4666 |
|
|
2019
Q2 | $249K | Buy |
+3,143
| New | +$249K | ﹤0.01% | 4680 |
|